SHPH - shuttlepharma.com Revenue Dynamics YoY (Last Twelve Months)

Public company logo of Shuttle Pharmaceuticals (SHPH)

Shuttle Pharmaceuticals (SHPH) total dependence on third-party laboratories and contractors contrasts with the development of breakthrough methods for enhancing radiation impact on brain tumors. This trailing twelve-month revenue chart helps correlate these factors, where 0.00 represents the current metric level. Currently, the business relies on the gradual depletion of existing cash reserves to fund critical scientific research.

SHPH shuttlepharma.com: Revenue Growth YoY (Last 12 Months) in the range 02/11/2024 - 11/17/2026

Summary analytical data breakdowns for Shuttle Pharmaceuticals Holdings (SHPH)

- stock value and consensus price forecast:
Summary company analytics:Shuttle Pharmaceuticals
Product sample of shuttlepharma.com

This indicator measures revenue dynamics over a rolling twelve-month period, allowing for an assessment of the actual business scaling speed and the risk of capital stagnation. By analyzing the Last Twelve Months (LTM) change in trading revenue, an investor can compare the sales growth rates of Shuttle Pharmaceuticals (SHPH) radiosensitizers with the expansion of oncology centers to determine the market potential of brain cancer therapy drugs.

Competitor analysis for Shuttle Pharmaceuticals